233 related articles for article (PubMed ID: 9413764)
1. Zinc in the human prostate gland: normal, hyperplastic and cancerous.
Zaichick VYe ; Sviridova TV; Zaichick SV
Int Urol Nephrol; 1997; 29(5):565-74. PubMed ID: 9413764
[TBL] [Abstract][Full Text] [Related]
2. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer.
Zaichick VY; Sviridova TV; Zaichick SV
Int Urol Nephrol; 1996; 28(5):687-94. PubMed ID: 9061429
[TBL] [Abstract][Full Text] [Related]
3. Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions.
Sapota A; Darago A; Taczalski J; Kilanowicz A
Biometals; 2009 Dec; 22(6):1041-9. PubMed ID: 19629715
[TBL] [Abstract][Full Text] [Related]
4. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
Feustel A; Wennrich R
Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
[TBL] [Abstract][Full Text] [Related]
5. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
Feustel A; Wennrich R; Steiniger D; Klauss P
Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
[TBL] [Abstract][Full Text] [Related]
7. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of ubiquitin in human prostate gland.
Bataineh ZM; Habbal O
Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
[TBL] [Abstract][Full Text] [Related]
9. Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate.
Dhar NK; Goel TC; Dube PC; Chowdhury AR; Kar AB
Exp Mol Pathol; 1973 Oct; 19(2):139-42. PubMed ID: 4127820
[No Abstract] [Full Text] [Related]
10. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
Ogunlewe JO; Osegbe DN
Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
[TBL] [Abstract][Full Text] [Related]
11. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
13. [Zinc levels in prostatic fluid of patients with prostate pathologies].
Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
[TBL] [Abstract][Full Text] [Related]
14. Transrectal fine needle aspiration of prostate.
Jayaram G; Nakra N; Verma AK; Goel GD
J Assoc Physicians India; 1993 Jun; 41(6):364-6. PubMed ID: 7516326
[TBL] [Abstract][Full Text] [Related]
15. Organ-wide telomeric status in diseased and disease-free prostatic tissues.
Heaphy CM; Fleet TM; Treat EG; Lee SJ; Smith AY; Davis MS; Griffith JK; Fischer EG; Bisoffi M
Prostate; 2010 Sep; 70(13):1471-9. PubMed ID: 20687220
[TBL] [Abstract][Full Text] [Related]
16. Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy.
Miličević N; Mrčela M; Galić J; Marjanović K
Pathol Res Pract; 2015 Nov; 211(11):865-70. PubMed ID: 26376467
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate].
Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S
Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842
[TBL] [Abstract][Full Text] [Related]
18. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value.
Vartsky D; Shilstein S; Bercovich A; Huszar M; Breskin A; Chechik R; Korotinsky S; Malnick SD; Moriel E
J Urol; 2003 Dec; 170(6 Pt 1):2258-62. PubMed ID: 14634392
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
20. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
